Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Enobosarm by Veru for Obesity: Likelihood of Approval
Enobosarm is under clinical development by Veru and currently in Phase II for Obesity. According to GlobalData, Phase II drugs...
Enobosarm by Veru for Muscle Wasting Disorders: Likelihood of Approval
Enobosarm is under clinical development by Veru and currently in Phase I for Muscle Wasting Disorders. According to GlobalData, Phase...
Risk adjusted net present value: What is the current valuation of Veru's Enobosarm?
Enobosarm is a small molecule commercialized by Veru, with a leading Phase II program in Obesity. According to Globaldata, it...
Risk adjusted net present value: What is the current valuation of Veru's Enobosarm?
Enobosarm is a small molecule commercialized by Veru, with a leading Phase II program in Obesity. According to Globaldata, it...